TNM 8th edition in thyroid cancer staging: is there an improvement in predicting recurrence?

in Endocrine-Related Cancer
View More View Less
  • 1 Endocrinology, Diabetology and Andrology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy
  • 2 Department of Medical-Surgical Sciences and Biotechnologies, ‘Sapienza’ University of Rome, Latina, Italy
  • 3 Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
  • 4 Endocrinology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
  • 5 Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy

Correspondence should be addressed to G Mazziotti: gherardo.mazziotti@hunimed.eu

*(O A Manzardo and M Cellini contributed equally to this work)

Restricted access

TNM 8th edition introduces changes in the staging of patients with differentiated thyroid carcinoma (DTC). This study aims at assessing the value of TNM 8th edition in predicting response to therapy and structural recurrence of DTC. Four hundred and eighty DTC patients were retrospectively evaluated by 7th and 8th editions of TNM staging system in relationship with risk stratification, response to therapy and recurrence of disease as defined by 2015 ATA guidelines. As compared to the 7th edition, TNM 8th led to downstage 136 patients (28.3%), with 97.5% of patients falling into lower stages (I–II) and only 2.5% remaining in higher stages (III–IV) (P < 0.001). Patients who were downstaged in stages I–II by TNM 8th were classified more frequently at intermediate-high risk (P < 0.001), had more frequently structural incomplete response to therapy (P = 0.009) and had higher risk of structural recurrence (P = 0.002) as compared to patients who were in the same TNM stages but were not downstaged. Specifically, the risk of structural recurrence was significantly higher in patients in whom the downstaging was induced by changes in tumour classification (hazard ratio (HR) 6.18, 95% CI 2.20–17.40; P = 0.001) but not in those who were downstaged for the increase in age cut-off (HR 2.80, 95% CI 0.86–9.19; P = 0.09). In conclusion, TNM 8th edition did not show reliability in predicting aggressiveness of DTC. In fact, the downstaging of DTC patients especially when performed due to changes in tumour classification may overlook patients predisposed to structural recurrence, potentially causing uncertainty in the therapeutic decision-making at the time of disease’s diagnosis.

 

Society for Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 1735 1661 99
Full Text Views 196 192 2
PDF Downloads 108 107 3
  • Adam MA, Pura J, Goffredo P, Dinan MA, Reed SD, Scheri RP, Hyslop T, Roman SA & Sosa JA 2015 Presence and number of lymph mode metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer. Journal of Clinical Oncology 33 23702375. (https://doi.org/10.1200/JCO.2014.59.8391)

    • Search Google Scholar
    • Export Citation
  • Al-Qurayshi Z, Shama MA, Randolph GW & Kandil E 2017 Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer. Endocrine-Related Cancer 24 221226. (https://doi.org/10.1530/ERC-16-0509)

    • Search Google Scholar
    • Export Citation
  • Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR & Winchester DP 2017 AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more ‘personalized’ approach to cancer staging. CA: A Cancer Journal for Clinicians 67 9399. (https://doi.org/10.3322/caac.21388)

    • Search Google Scholar
    • Export Citation
  • Biondi B & Cooper DS 2010 Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 20 135146. (https://doi.org/10.1089/thy.2009.0311)

    • Search Google Scholar
    • Export Citation
  • Brierley JD, Gospodarowicz MK & Wittekind C 2017 The principles of the TNM system. In The TNM Classification of Malignant Tumours, 8th ed., pp. 23. Oxford, UK: John Wiley & Sons, Ltd.

    • Search Google Scholar
    • Export Citation
  • Castagna MG, Maino F, Cipri C, Belardini V, Theodoropoulou A, Cevenini G & Pacini F 2011 Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients. European Journal of Endocrinology 165 441446. (https://doi.org/10.1530/EJE-11-0466)

    • Search Google Scholar
    • Export Citation
  • Castagna MG, Forleo R, Maino F, Fralassi N, Barbato F, Palmitesta P, Pilli T, Capezzone M, Brilli L, Ciuoli C, et al. 2018 Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor. Journal of Endocrinological Investigation 41 10291035. (https://doi.org/10.1007/s40618-018-0854-8)

    • Search Google Scholar
    • Export Citation
  • Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL & Trotti A 2010 AJCC Cancer Staging Manual, 7th ed. New York, NY, USA: Springer.

  • Fiteni F, Westeel V, Pivot X, Borg C, Vernerey D & Bonnetain F 2014 Endpoints in cancer clinical trials. Journal of Visceral Surgery 151 1722. (https://doi.org/10.1016/j.jviscsurg.2013.10.001)

    • Search Google Scholar
    • Export Citation
  • Ganly I, Nixon IJ, Wang LY, Palmer FL, Migliacci JC, Aniss A, Sywak M, Eskander AE, Freeman JL, Campbell MJ, et al. 2015 Survival from differentiated thyroid cancer: what has age got to do with it? Thyroid 25 11061114. (https://doi.org/10.1089/thy.2015.0104)

    • Search Google Scholar
    • Export Citation
  • Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, et al. 2016 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26 1133. (https://doi.org/10.1089/thy.2015.0020)

    • Search Google Scholar
    • Export Citation
  • Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K & Miyauchi A 2006a Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surgery Today 36 1218. (https://doi.org/10.1007/s00595-005-3090-8)

    • Search Google Scholar
    • Export Citation
  • Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K & Miyauchi A 2006b Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World Journal of Surgery 30 780786. (https://doi.org/10.1007/s00268-005-0270-z)

    • Search Google Scholar
    • Export Citation
  • Kim M, Kim WG, Oh HS, Park S, Kwon H, Song DE, Kim TY, Shong YK, Kim WB, Sung TY, et al. 2017a Comparison of the seventh and eighth editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging system for differentiated thyroid cancer. Thyroid 27 11491155. (https://doi.org/10.1089/thy.2017.0050)

    • Search Google Scholar
    • Export Citation
  • Kim M, Kim YN, Kim WG, Park S, Kwon H, Jeon MJ, Ahn HS, Jung SH, Kim SW, Kim WB, et al. 2017b Optimal cut-off age in the TNM staging system of differentiated thyroid cancer: is 55 years better than 45 years? Clinical Endocrinology 86 438443. (https://doi.org/10.1111/cen.13254)

    • Search Google Scholar
    • Export Citation
  • Kim TH, Kim YN, Kim HI, Park SY, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, et al. 2017c Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma. Oral Oncology 71 8186. (https://doi.org/10.1016/j.oraloncology.2017.06.004)

    • Search Google Scholar
    • Export Citation
  • Kim M, Jeon MJ, Oh HS, Park S, Song DE, Sung TY, Kim TY, Chung KW, Kim WB, Shong YK, et al. 2018a Prognostic implication of N1b classification in the eighth edition of the tumor-node-metastasis staging system of differentiated thyroid cancer. Thyroid 28 496503. (https://doi.org/10.1089/thy.2017.0473)

    • Search Google Scholar
    • Export Citation
  • Kim M, Kim HI, Jeon MJ, Kim HK, Kim EH, Yi HS, Kim ES, Kim H, Kim BH, Kim TY, et al. 2018b Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: a multicenter cohort study. Oral Oncology 87 97103. (https://doi.org/10.1016/j.oraloncology.2018.10.029)

    • Search Google Scholar
    • Export Citation
  • Kim M, Kim HK, Kim HI, Kim EH, Jeon MJ, Yi HS, Kim ES, Kim H, Kim TH, Kim BH, et al. 2018c Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: a multi-institutional cohort study. Oral Oncology 86 4852. (https://doi.org/10.1016/j.oraloncology.2018.09.008)

    • Search Google Scholar
    • Export Citation
  • Klein Hesselink EN, Klein Hesselink MS, de Bock GH, Gansevoort RT, Bakker SJ, Vredeveld EJ, van der Horst-Schrivers AN, van der Horst IC, Kamphuisen PW, Plukker JT, et al. 2013 Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study. Journal of Clinical Oncology 31 40464053. (https://doi.org/10.1200/JCO.2013.49.1043)

    • Search Google Scholar
    • Export Citation
  • Lamartina L, Grani G, Arvat E, Nervo A, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Massa M, et al. 2018 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocrine-Related Cancer 25 L7L11. (https://doi.org/10.1530/ERC-17-0453)

    • Search Google Scholar
    • Export Citation
  • Lee SG, Lee WK, Lee HS, Moon J, Lee CR, Kang SW, Jeong JJ, Nam KH, Chung WY, Jo YS, et al. 2017 Practical performance of the 2015 American Thyroid Association guidelines for predicting tumor recurrence in patients with papillary thyroid cancer in South Korea. Thyroid 27 174181. (https://doi.org/10.1089/thy.2016.0252)

    • Search Google Scholar
    • Export Citation
  • Mazziotti G, Formenti AM, Frara S, Olivetti R, Banfi G, Memo M, Maroldi R, Giubbini R & Giustina A 2018 High prevalence of radiological vertebral fractures in women on thyroid-stimulating hormone-suppressive therapy for thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 103 956964. (https://doi.org/10.1210/jc.2017-01986)

    • Search Google Scholar
    • Export Citation
  • Momesso DP & Tuttle RM 2014 Update on differentiated thyroid cancer staging. Endocrinology and Metabolism Clinics of North America 43 401421. (https://doi.org/10.1016/j.ecl.2014.02.010)

    • Search Google Scholar
    • Export Citation
  • Momesso DP, Vaisman F, Yang SP, Bulzico DA, Corbo R, Vaisman M & Tuttle RM 2016 Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine. Journal of Clinical Endocrinology and Metabolism 101 26922700. (https://doi.org/10.1210/jc.2015-4290)

    • Search Google Scholar
    • Export Citation
  • Nam SH, Bae MR, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY & Kim SY 2018 A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma. Oral Oncology 87 158164. (https://doi.org/10.1016/j.oraloncology.2018.11.003)

    • Search Google Scholar
    • Export Citation
  • Nava CF, Zanella AB, Scheffel RS, Maia AL & Dora JM 2019 Impact of the updated TNM staging criteria on prediction of persistent disease in a differentiated thyroid carcinoma cohort. Archives of Endocrinology and Metabolism 63 511. (https://doi.org/10.20945/2359-3997000000097)

    • Search Google Scholar
    • Export Citation
  • Pacini F, Basolo F, Bellantone R, Boni G, Cannizzaro MA, De Palma M, Durante C, Elisei R, Fadda G, Frasoldati A, et al. 2018 Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. Journal of Endocrinological Investigation 41 849876. (https://doi.org/10.1007/s40618-018-0884-2)

    • Search Google Scholar
    • Export Citation
  • Pontius LN, Oyekunle TO, Thomas SM, Stang MT, Scheri RP, Roman SA & Sosa JA 2017 Projecting survival in papillary thyroid cancer: a comparison of the seventh and eighth editions of the American Joint Commission on Cancer/Union for International Cancer Control staging systems in two contemporary national patient cohorts. Thyroid 27 14081416. (https://doi.org/10.1089/thy.2017.0306)

    • Search Google Scholar
    • Export Citation
  • Sampson E, Brierley JD, Le LW, Rotstein L & Tsang RW 2007 Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 110 14511456. (https://doi.org/10.1002/cncr.22956)

    • Search Google Scholar
    • Export Citation
  • Santos MJ & Bugalho MJ 2016 Papillary thyroid carcinoma: different clinical behavior among pT3 tumors. Endocrine 53 754760. (https://doi.org/10.1007/s12020-016-0927-4)

    • Search Google Scholar
    • Export Citation
  • Schmid KW, Synoracki S, Dralle H & Wittekind C 2019 Proposal for an extended pTNM classification of thyroid carcinoma: commentary on deficits of the 8th edition of the TNM classification. Der Pathologe 40 1824. (https://doi.org/10.1007/s00292-018-0418-x)

    • Search Google Scholar
    • Export Citation
  • Schmidbauer B, Menhart K, Hellwig D & Grosse J 2017 Differentiated thyroid cancer-treatment: state of the art. International Journal of Molecular Sciences 18 E1292. (https://doi.org/10.3390/ijms18061292)

    • Search Google Scholar
    • Export Citation
  • Shin JH, Ha TK, Park HK, Ahn MS, Kim KH, Bae KB, Kim TH, Choi CS, Kim TK, Bae SK, et al. 2013 Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma. International Journal of Surgery 11 944947. (https://doi.org/10.1016/j.ijsu.2013.06.015)

    • Search Google Scholar
    • Export Citation
  • Shteinshnaider M, Muallem Kalmovich L, Koren S, Or K, Cantrell D & Benbassat C 2018 Reassessment of differentiated thyroid cancer patients using the eighth TNM/AJCC classification system: a comparative study. Thyroid 28 201209. (https://doi.org/10.1089/thy.2017.0265)

    • Search Google Scholar
    • Export Citation
  • Sugitani I, Fujimoto Y & Yamamoto N 2008 Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 143 3542. (https://doi.org/10.1016/j.surg.2007.06.011)

    • Search Google Scholar
    • Export Citation
  • Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, et al. 2018 Survival in differentiated thyroid cancer: comparing the AJCC cancer staging seventh and eighth editions. Thyroid 28 13011310. (https://doi.org/10.1089/thy.2017.0572)

    • Search Google Scholar
    • Export Citation
  • Tran B, Roshan D, Abraham E, Wang L, Garibotto N, Wykes J, Campbell P & Ebrahimi A 2018 An analysis of the American Joint Committee on Cancer, 8th edition T staging system for papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 103 21992206. (https://doi.org/10.1210/jc.2017-02551)

    • Search Google Scholar
    • Export Citation
  • Tuttle RM & Leboeuf R 2008 Follow up approaches in thyroid cancer: a risk adapted paradigm. Endocrinology and Metabolism Clinics of North America 37 419435, ix. (https://doi.org/10.1016/j.ecl.2008.02.008)

    • Search Google Scholar
    • Export Citation
  • Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA & Shaha A 2010 Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 20 13411349. (https://doi.org/10.1089/thy.2010.0178)

    • Search Google Scholar
    • Export Citation
  • Vaisman F, Momesso D, Bulzico DA, Pessoa CH, Dias F, Corbo R, Vaisman M & Tuttle RM 2012 Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. Clinical Endocrinology 77 132138. (https://doi.org/10.1111/j.1365-2265.2012.04342.x)

    • Search Google Scholar
    • Export Citation
  • Verburg FA, Mäder U, Luster M & Reiners C 2018 The effects of the Union for International Cancer Control/American Joint Committee on cancer tumour, node, metastasis system version 8 on staging of differentiated thyroid cancer: a comparison to version 7. Clinical Endocrinology 88 950956. (https://doi.org/10.1111/cen.13597)

    • Search Google Scholar
    • Export Citation
  • Yin DT, Yu K, Lu RQ, Li X, Xu J & Lei M 2016 Prognostic impact of minimal extrathyroidal extension in papillary thyroid carcinoma. Medicine 95 e5794. (https://doi.org/10.1097/MD.0000000000005794)

    • Search Google Scholar
    • Export Citation
  • Youngwirth LM, Adam MA, Scheri RP, Roman SA & Sosa JA 2017 Extrathyroidal extension is associated with compromised survival in patients with thyroid cancer. Thyroid 27 626631. (https://doi.org/10.1089/thy.2016.0132)

    • Search Google Scholar
    • Export Citation